These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 24785459)

  • 21. Microarray analysis of differentially expressed microRNAs in allergic rhinitis.
    Shaoqing Y; Ruxin Z; Guojun L; Zhiqiang Y; Hua H; Shudong Y; Jie Z
    Am J Rhinol Allergy; 2011; 25(6):e242-6. PubMed ID: 22185732
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Salivary microRNAs show potential as a noninvasive biomarker for detecting resectable pancreatic cancer.
    Xie Z; Yin X; Gong B; Nie W; Wu B; Zhang X; Huang J; Zhang P; Zhou Z; Li Z
    Cancer Prev Res (Phila); 2015 Feb; 8(2):165-73. PubMed ID: 25538087
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MicroRNA-10a is overexpressed in human pancreatic cancer and involved in its invasiveness partially via suppression of the HOXA1 gene.
    Ohuchida K; Mizumoto K; Lin C; Yamaguchi H; Ohtsuka T; Sato N; Toma H; Nakamura M; Nagai E; Hashizume M; Tanaka M
    Ann Surg Oncol; 2012 Jul; 19(7):2394-402. PubMed ID: 22407312
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MicroRNAs as diagnostic markers for pancreatic ductal adenocarcinoma and its precursor, pancreatic intraepithelial neoplasm.
    Xue Y; Abou Tayoun AN; Abo KM; Pipas JM; Gordon SR; Gardner TB; Barth RJ; Suriawinata AA; Tsongalis GJ
    Cancer Genet; 2013 Jun; 206(6):217-21. PubMed ID: 23933230
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Microarray analysis of microRNA expression in cutaneous squamous cell carcinoma.
    Sand M; Skrygan M; Georgas D; Sand D; Hahn SA; Gambichler T; Altmeyer P; Bechara FG
    J Dermatol Sci; 2012 Dec; 68(3):119-26. PubMed ID: 23026055
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of a miRNA-based diagnostic assay for pancreatic ductal adenocarcinoma.
    Szafranska-Schwarzbach AE; Adai AT; Lee LS; Conwell DL; Andruss BF
    Expert Rev Mol Diagn; 2011 Apr; 11(3):249-57. PubMed ID: 21463235
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Integrating a microRNA signature as a liquid biopsy-based tool for the early diagnosis and prediction of potential therapeutic targets in pancreatic cancer.
    Shi W; Wartmann T; Accuffi S; Al-Madhi S; Perrakis A; Kahlert C; Link A; Venerito M; Keitel-Anselmino V; Bruns C; Croner RS; Zhao Y; Kahlert UD
    Br J Cancer; 2024 Jan; 130(1):125-134. PubMed ID: 37950093
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Differential expression of hsa-miR-126 and hsa-miR-518b in esophageal squamous carcinoma].
    Cai H; Wang JS; Zhang MX; Duan XY; Ma RQ
    Nan Fang Yi Ke Da Xue Xue Bao; 2011 Jan; 31(1):23-7. PubMed ID: 21269950
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Road to early detection of pancreatic cancer: Attempts to utilize epigenetic biomarkers.
    Fukushige S; Horii A
    Cancer Lett; 2014 Jan; 342(2):231-7. PubMed ID: 22450751
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Downregulation of miR-132 by promoter methylation contributes to pancreatic cancer development.
    Zhang S; Hao J; Xie F; Hu X; Liu C; Tong J; Zhou J; Wu J; Shao C
    Carcinogenesis; 2011 Aug; 32(8):1183-9. PubMed ID: 21665894
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [miRNA-192, miRNA-21 and miRNA-200: new pancreatic cancer markers in diabetic patients?].
    Škrha P; Hořínek A; Anděl M; Škrha J
    Vnitr Lek; 2015 Apr; 61(4):351-4. PubMed ID: 25894267
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Machine Learning Method for a Blood Diagnostic Model of Pancreatic Cancer Based on microRNA Signatures.
    Huang B; Xin C; Yan H; Yu Z
    Crit Rev Immunol; 2024; 44(3):13-23. PubMed ID: 38421702
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Emerging roles of microRNAs in pancreatic cancer diagnosis, therapy and prognosis (Review).
    Subramani R; Gangwani L; Nandy SB; Arumugam A; Chattopadhyay M; Lakshmanaswamy R
    Int J Oncol; 2015 Oct; 47(4):1203-10. PubMed ID: 26314882
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Diagnosis, treatment and prognosis evaluation of pancreatic cancer by microRNA].
    Ren H; Wang CF
    Zhonghua Zhong Liu Za Zhi; 2020 Nov; 42(11):903-906. PubMed ID: 33256299
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hsa-miR-4730 as a new and potential diagnostic and prognostic indicators for pancreatic cancer.
    Yang W; Ju HY; Tian XF
    Eur Rev Med Pharmacol Sci; 2020 Sep; 24(17):8801-8811. PubMed ID: 32964968
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Integrative analysis of multi-omics data for identifying multi-markers for diagnosing pancreatic cancer.
    Kwon MS; Kim Y; Lee S; Namkung J; Yun T; Yi SG; Han S; Kang M; Kim SW; Jang JY; Park T
    BMC Genomics; 2015; 16 Suppl 9(Suppl 9):S4. PubMed ID: 26328610
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Tumor marker of pancreatic tumor].
    Ajihara T; Shimizu K; Shiratori K
    Nihon Rinsho; 2015 Mar; 73 Suppl 3():45-9. PubMed ID: 25856984
    [No Abstract]   [Full Text] [Related]  

  • 38. MiRNAs as biomarkers of high-risk pancreatic cysts: a possible holy grail for the early detection of pancreatic cancer.
    Permuth JB; Georgeades C; Malafa M
    Future Oncol; 2015; 11(23):3105-8. PubMed ID: 26549701
    [No Abstract]   [Full Text] [Related]  

  • 39. Evaluation of potential of miR-8073 and miR-642 as diagnostic markers in pancreatic cancer.
    Fathi M; Aghdaie HA; Ghafouri-Fard S; Shams R
    Mol Biol Rep; 2022 Jul; 49(7):6475-6481. PubMed ID: 35596051
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Circulating microRNAs Expressions as Genetic Biomarkers in Pancreatic Cancer Patients Continuous Non-Invasive Monitoring.
    Sandesc M; Dinu A; Rogobete AF; Bedreag OH; Sandesc D; Papurica M; Bratu LM; Negoita S; Vernic C; Popovici SE; Corneci D
    Clin Lab; 2017 Oct; 63(10):1561-1566. PubMed ID: 29035444
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.